2024 Endocrinology Grand Rounds | Transgender Medicine
A transgender person is someone whose gender identity differs from that typically associated with the sex they were assigned at birth. Awareness and acceptance of transgender people in the United States has increased, which has resulted in "more" transgenders, as they are more inclined to openly identifying themselves as such. Transgender patients require effective and safe treatment, which may include the need for hormone therapy, monitoring of maintenance levels, risks and complications. Endocrinologists play an integral role in transgender medicine.
The field of transgender care in endocrinology has always been a difficult and challenging topic. The patient care for this patient population is very delicate and requires the latest knowledge in the field. It is imperative that clinicians be kept up to date and abreast of the latest advancements in the field of diabetes, endocrinology & metabolism pertaining to the transgender community in order to improve patient care quality, as well as generate avenues for clinical research collaborations.
Faculty and Staff of department of Diabetes, Endocrinology and Metabolism.
- Examine initial evaluation of transgender patients.
- Discuss hormone therapy.
- Outline follow up and monitoring of transgender patients.
- Identify complications of therapy.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Virtual Meeting- Zoom
Michael S. Irwig MD Director of Transgender Medicine, Beth Israel Deaconess Medical Center; Associate Professor of Medicine, Harvard Medical School
Presenter: Dr. Irwig has indicated that there are no relevant financial relationships.
Dr. Irwig will be discussing the off-label or investigational use of Testosterone, Estradiol, and Spironolactone.
Planner: Pooja Manroa, MD has indicated that there are no relevant financial relationships.
This presentation and/or comments will provide a balanced, non-promotional, and evidence-based approach to all diagnostic, therapeutic and/or research related content.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2024 Endocrinology Grand Rounds | Transgender Medicine for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance